The N METHYLTHISTAMINE, RANDOM, U test contains 1 test with 2 biomarkers.
Screening for and monitoring of mastocytosis and
disorders of systemic mast-cell activation, such as
anaphylaxis and other forms of severe systemic allergic reactions.
Monitoring therapeutic progress in conditions that are associated with secondary, localized, low-grade persistent, mast-cell proliferation and activation such as interstitial cystitis.
The following is a list of what is included in the item above. Click the test(s) below to view what biomarkers are measured along with an explanation of what the biomarker is measuring.